PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.96%
Revenue growth above 1.5x IXX.DE's 1.91%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
14.44%
Positive gross profit growth while IXX.DE is negative. John Neff would see a clear operational edge over the competitor.
141.21%
Positive EBIT growth while IXX.DE is negative. John Neff might see a substantial edge in operational management.
133.19%
Positive operating income growth while IXX.DE is negative. John Neff might view this as a competitive edge in operations.
116.53%
Positive net income growth while IXX.DE is negative. John Neff might see a big relative performance advantage.
116.41%
Positive EPS growth while IXX.DE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
116.41%
Positive diluted EPS growth while IXX.DE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.50%
Dividend growth of 9.50% while IXX.DE is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-23.68%
Negative OCF growth while IXX.DE is at 10.98%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-22.64%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
67.14%
10Y revenue/share CAGR at 50-75% of IXX.DE's 132.21%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
31.65%
5Y revenue/share CAGR under 50% of IXX.DE's 75.01%. Michael Burry would suspect a significant competitive gap or product weakness.
1.98%
3Y revenue/share CAGR under 50% of IXX.DE's 33.61%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.79%
Negative 3Y OCF/share CAGR while IXX.DE stands at 333.61%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
56.28%
Positive 10Y CAGR while IXX.DE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-4.30%
Negative 5Y net income/share CAGR while IXX.DE is 19.23%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-66.67%
Negative 3Y CAGR while IXX.DE is 43.90%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
142.29%
10Y equity/share CAGR 1.25-1.5x IXX.DE's 106.45%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
105.17%
5Y equity/share CAGR above 1.5x IXX.DE's 28.63%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
71.57%
3Y equity/share CAGR above 1.5x IXX.DE's 14.58%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
5.28%
Inventory shrinking or stable vs. IXX.DE's 10.70%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
3.81%
Asset growth well under 50% of IXX.DE's 11.03%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
3.05%
Positive BV/share change while IXX.DE is negative. John Neff sees a clear edge over a competitor losing equity.
-2.24%
We’re deleveraging while IXX.DE stands at 29.53%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-14.19%
We cut SG&A while IXX.DE invests at 0.12%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.